Crispr Therapeutics

This weekend's Barron's cover story looks at why pharmaceutical giants are making big bets on gene therapy. See which companies already have been snapped up and which ones may be the next targets. Other notable articles offer a look at the implications of the tax law and a retirement guide...

This weekend's Barron's cover story looks at why pharmaceutical giants are making big bets on gene therapy. Other featured articles examine problems with packaged food companies and which high-yield dividends are safest. Also, the prospects for a weight-loss products leader and a fashion...